Detalles de la búsqueda
1.
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial.
Lancet
; 403(10432): 1141-1152, 2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38461841
2.
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results.
Ophthalmology
; 130(7): 735-747, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36870451
3.
Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment: Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Program.
Ophthalmology
; 127(10): 1405-1415, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32564920
4.
Randomized Trial of Treat and Extend Ranibizumab with and without Navigated Laser for Diabetic Macular Edema: TREX-DME 1 Year Outcomes.
Ophthalmology
; 124(1): 74-81, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27836430
5.
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-Week Results of the VIBRANT Study.
Ophthalmology
; 123(2): 330-336, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26522708
6.
Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA).
Ophthalmology
; 123(11): 2413-2423, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27692526
7.
Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study.
Ophthalmology
; 122(3): 538-44, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25315663
8.
Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study.
Ophthalmology
; 121(7): 1414-1420.e1, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24679444
9.
Exudation in Patients With Neovascular Age-Related Macular Degeneration Treated With the Port Delivery System or Monthly Injections.
Am J Ophthalmol
; 258: 158-172, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37453472
10.
Retinopathy Regression with Treat and Extend Ranibizumab for Diabetic Macular Edema.
Ophthalmology
; 125(8): 1304-1306, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29729809
11.
Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial.
JAMA Ophthalmol
; 141(9): 834-842, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37535382
12.
Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study.
Ophthalmology
; 119(5): 1024-32, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22440275
14.
Long-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year results.
Br J Ophthalmol
; 105(2): 253-257, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32303499
15.
Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial.
JAMA Ophthalmol
; 139(9): 946-955, 2021 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34351414
16.
Randomized Trial of Treat and Extend Ranibizumab With and Without Navigated Laser Versus Monthly Dosing for Diabetic Macular Edema: TREX-DME 2-Year Outcomes.
Am J Ophthalmol
; 202: 91-99, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30771333
17.
Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration.
J Manag Care Spec Pharm
; 24(2-a Suppl): S3-S15, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29383980
18.
Neovascular age-related macular degeneration management in the third year: final results from the TREX-AMD randomised trial.
Br J Ophthalmol
; 102(4): 460-464, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28779006
19.
Long-term Safety and Visual Outcome of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: VIEW 1 Extension Study.
Ophthalmol Retina
; 1(4): 304-313, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-31047516
20.
Randomized Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration: 2-Year Results of the TREX-AMD Study.
Ophthalmol Retina
; 1(4): 314-321, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-31047517